PepGen Inc.(PEPG)

Biotechnology · Boston, MA

$2.31-0.05 (-2.12%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

EV/EBITDA Ratio: N/A

Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.

The EV/EBITDA ratio is N/A as of 2026-10-06T22:13:04.023Z.

Stored calculation inputs

Calculation as of: 2026-10-06T22:13:04.023Z.

Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 159,780,875
Total debt · period ending 2026-06-30: 16,093,000
Cash · period ending 2026-06-30: 22,764,000
TTM operating EBITDA · period ending 2026-06-30: -70,149,000

FMP input reference: 4553d85706fed5bac33927ddb0c45062b9ca990621471d16f8faa1ad8920ffc8

EV/Sales|P/E Ratio|EBITDA|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

PEPG EV/EBITDA Ratio Metrics

EV/EBITDA RATIO

N/A

PEPG Competitors' EV/EBITDA Ratio

PEPG

PepGen Inc.

Current

Market Cap

$159.78M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NERV

Minerva Neurosciences, Inc.

vs PEPG

Market Cap

$159.80M

EV/EBITDA Ratio

N/A

TTM Avg

22.86x

3Y Avg

22.86x

5Y Avg

22.86x

LFMDP

LifeMD, Inc.

vs PEPG

Market Cap

$159.22M

EV/EBITDA Ratio

N/A

TTM Avg

159.13x

3Y Avg

159.13x

5Y Avg

159.13x

CHRS

Coherus Oncology, Inc.

vs PEPG

Market Cap

$159.14M

EV/EBITDA Ratio

N/A

TTM Avg

8.39x

3Y Avg

66.32x

5Y Avg

66.32x

QTRX

Quanterix Corporation

vs PEPG

Market Cap

$162.04M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

INGN

Inogen, Inc.

vs PEPG

Market Cap

$156.22M

EV/EBITDA Ratio

N/A

TTM Avg

29.09x

3Y Avg

58.55x

5Y Avg

59.27x

NKTX

Nkarta, Inc.

vs PEPG

Market Cap

$165.27M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

OPRX

OptimizeRx Corp.

vs PEPG

Market Cap

$165.32M

EV/EBITDA Ratio

10.41x

TTM Avg

86.42x

3Y Avg

168.75x

5Y Avg

173.55x

STIM

Neuronetics, Inc.

vs PEPG

Market Cap

$153.79M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

MENS

Jyong Biotech Ltd. Ordinary Shares

vs PEPG

Market Cap

$153.58M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EV/EBITDA RATIO	TTM	3Y	5Y
PepGen Inc. (PEPG)	$159.78M	N/A	N/A	N/A	N/A
Minerva Neurosciences, Inc. (NERV)vs ›	$159.80M	N/A	22.86x	22.86x	22.86x
LifeMD, Inc. (LFMDP)vs ›	$159.22M	N/A	159.13x	159.13x	159.13x
Coherus Oncology, Inc. (CHRS)vs ›	$159.14M	N/A	8.39x	66.32x	66.32x
Quanterix Corporation (QTRX)vs ›	$162.04M	N/A	N/A	N/A	N/A
Inogen, Inc. (INGN)vs ›	$156.22M	N/A	29.09x	58.55x	59.27x
Nkarta, Inc. (NKTX)vs ›	$165.27M	N/A	N/A	N/A	N/A
OptimizeRx Corp. (OPRX)vs ›	$165.32M	10.41x	86.42x	168.75x	173.55x
Neuronetics, Inc. (STIM)vs ›	$153.79M	N/A	N/A	N/A	N/A
Jyong Biotech Ltd. Ordinary Shares (MENS)vs ›	$153.58M	N/A	N/A	N/A	N/A

EV/EBITDA Ratio Formula & Definition

EV/EBITDA = Enterprise Value / EBITDA (TTM)

Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Related Metrics

EV/Sales P/E Ratio EBITDA All Metrics